- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
LENZ Therapeutics Inc (LENZ)
The LENZ Therapeutics share price today is 3.05, view NASDAQ LENZ stock exchange data. Track the latest LENZ Therapeutics share price with real-time updates on LENZ stock performance including market cap, day range, 52-week range and dividend yield. Access LENZ charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.04
3.43
52 wk Range
3.00
32.13
LENZ is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.043.43
52 wk Range
3.0032.13
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LENZ Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
18.67
Upside
+512.02%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Form 8K LENZ Therapeutics Inc For: 28 October- Investing.com
Graphite Bio receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Graphite Bio receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 18.67
(+512.02% Upside)
LENZ Therapeutics Inc Earnings Call Summary for Q3/2026
- LENZ posted Q3 loss of $0.99/share vs. est. $0.91; revenue $3.38M missed forecast of $4.5M by 25%, though shares rose 2.8% to $3.30
- VIZZ product revenue jumped 50% sequentially to $2.6M; paid scripts climbed 51% to 38K+, with telehealth driving over half of new prescriptions
- Company announced major restructuring cutting operating expenses 50%+ to $70-75M in 2027, shifting 70%+ of spending to consumer marketing
- CEO Paddock steps down Dec. 1; CFO Chevallard becomes interim CEO as board searches for permanent replacement amid strategic pivot
- VIZZ holds 94% U.S. market share in presbyopia drops; 11 international regulatory submissions pending as company refocuses on direct-to-consumer model
Last Updated: 29-10-2026, 07:08 pm
Read Full TranscriptEarnings
Latest Release
28-10-2026
EPS / Forecast
-0.99 / -0.91
Revenue / Forecast
3.38M / 4.5M
Compare LENZ to Peers and Sector
Metrics to compare | LENZ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLENZPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | 0.6x | −0.3x | |
PEG Ratio | 0.01 | −0.49 | 0.00 | |
Price/Book | 0.4x | 1.9x | 2.6x | |
Price / LTM Sales | 7.8x | 4.4x | 2.8x | |
Upside (Analyst Target) | - | 37.0% | 66.6% | |
Fair Value Upside | Unlock | 9.7% | 9.1% | Unlock |
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the LENZ Therapeutics (LENZ) Share Price Today?
The LENZ Therapeutics share price today is 3.05.
What is the current LENZ Therapeutics (LENZ) share price and day range?
As of 31-10-2026, the LENZ Therapeutics share price is 3.05, with a previous close of 3.49. The share price has ranged from 3.04 to 3.43 today, while the 52-week range spans from 3.00 to 32.13.
What Is the LENZ Therapeutics Market Cap?
As of today, LENZ Therapeutics market cap is 109.66M.
What Is the LENZ Therapeutics (LENZ) Share Price Target?
The average 12-month share price target for LENZ Therapeutics is 18.67, with a high estimate of 45 and a low estimate of 4. 4 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +512.02% Upside potential.
What Is LENZ Therapeutics's Earnings Per Share (TTM)?
The LENZ Therapeutics EPS (TTM) is -4.48.
When Is the Next LENZ Therapeutics Earnings Date?
LENZ Therapeutics will release its next earnings report on 24-03-2027.
From a Technical Analysis Perspective, Is LENZ a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does LENZ Therapeutics Trade On?
LENZ Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for LENZ Therapeutics?
The stock symbol for LENZ Therapeutics is "LENZ."
How Many Times Has LENZ Therapeutics Stock Split?
LENZ Therapeutics has split 1 times.
How Many Employees Does LENZ Therapeutics Have?
LENZ Therapeutics has 152 employees.
What Is the LENZ Premarket Price?
LENZ's last pre-market stock price is 3.21. The pre-market share volume is 860.00, and the stock has changed by -0.28, or -8.02%.
What Is the LENZ After Hours Price?
LENZ's last after hours stock price is 3.09, the stock has changed by 0.04, or 1.31%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.